Search

Lenzumestrocel (CorestemChemon Inc.) for Amyotrophic Lateral Sclerosis

An intrathecal autologous mesenchymal stem cell therapy under investigation for treatment of amyotrophic lateral sclerosis.

Complete this form to request the full report